UBS Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
|
|||||
|
2025
Q1 | $15.2M | Buy |
|
|||||
|
2024
Q4 | $13.2M | Sell |
|
|||||
|
2024
Q3 | $181M | Sell |
|
|||||
|
2024
Q2 | $139M | Buy |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $1.06M | Buy |
|
|||||
|
2023
Q3 | $289K | Buy |
|
|||||
|
2023
Q2 | $36.9K | Buy |
|
|||||
|
2023
Q1 | $7.29K | Sell |
|
|||||
|
2022
Q4 | $37.8K | Sell |
|
|||||
|
2022
Q3 | $54K | Buy |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $51K | Sell |
|
|||||
|
2021
Q4 | $178K | Buy |
|
|||||
|
2021
Q3 | $59K | Sell |
|
|||||
|
2021
Q2 | $103K | Buy |
|
|||||
|
2021
Q1 | $74K | Sell |
|
|||||
|
2020
Q4 | $247K | Buy |
|
|||||
|
2020
Q3 | $164K | Sell |
|
|||||
|
2020
Q2 | $387K | Buy |
|
|||||
|
2020
Q1 | $43K | Buy |
|
|||||
|
2019
Q4 | $27K | Sell |
|
|||||
|
2019
Q3 | $22K | Sell |
|
|||||
|
2019
Q2 | $167K | Sell |
|
|||||
|
2019
Q1 | $586K | Sell |
|
|||||
|
2018
Q4 | $1.02M | Buy |
|
|||||
|
2018
Q3 | $1.11M | Sell |
|
|||||
|
2018
Q2 | $931K | Buy |
|